articleNew England Journal of MedicineMar 14, 2010BRONZE OA

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

TAThe ACCORD Study Group
PubMed
Indexed incrossrefpubmed

Abstract

BACKGROUND: There is no evidence from randomized trials to support a strategy of lowering systolic blood pressure below 135 to 140 mm Hg in persons with type 2 diabetes mellitus. We investigated whether therapy targeting normal systolic pressure (i.e.,

Citation impact

3,602
total citations
FWCI
193.98
Percentile
100%
References
21
Citations per year

Authors

1
  • TA
    The ACCORD Study GroupCorresponding

Topics & keywords

Topics
Keywords
  • Medicine
  • Blood pressure
  • Diabetes mellitus
  • Type 2 Diabetes Mellitus
  • Internal medicine
  • Randomized controlled trial
  • Type 2 diabetes
  • Cardiology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.